News | Careers |Contact
Global

Another MNC! Great Bay Bio has added another overseas order

2023-10-18

香港
10月18日

继上周后，大湾生物再与一家跨国企业（MNC）签订培养基开发合作协议，再次展现大湾生物多维度参与国际无血清培养基市场开发和供应的能力。

同时，通过本次合作，该MNC将迅速推进无血清细胞培养基的新原料发现与验证，及培养基工艺的深度优化，将大幅提高生物制品研发和培养基供应效率，提升无血清细胞培养基的未来发展。


Back
Recent News
Technology Platform | AI-Enabled Antibody Molecular Engineering: Iterative Optimization of the AlfaDAX Platform Breaks Through Traditional R&D Bottlenecks

Technology Platform | AI-Enabled Antibody Molecular Engineering: Iterative Optimization of the AlfaDAX Platform Breaks Through Traditional R&D Bottlenecks

2026-06-03
Great Bay Bio Establishes Strategic Partnership with a Global Leading Biosimilar Enterprise to Accelerate Global Adoption of AlfaCell Platform

Great Bay Bio Establishes Strategic Partnership with a Global Leading Biosimilar Enterprise to Accelerate Global Adoption of AlfaCell Platform

2026-05-20
Great Bay Bio’s AlfaCell Delivers Average Titer Above 6.9 g/L Across Client Projects, with RCB Completed in Just 1.5 Months

Great Bay Bio’s AlfaCell Delivers Average Titer Above 6.9 g/L Across Client Projects, with RCB Completed in Just 1.5 Months

2026-03-27
Global Bioprocessing Made Simpler and More Efficient
Schedule a Meeting

Schedule a Meeting

I agree to the privacy policy.

Submit
COPYRIGHT 2026 © Great Bay Bio ALL RIGHTS RESERVD.